Corporate / CVCDr Reddy's Ventures
StagesSeed, Series A
SectorsHealthcare / Medtech, Deep Tech · Early-stage builders, Founder-led / operator capital
TicketNot listed
Corporate / CVCApollo Connect / Apollo Hospitals Ventures focuses on Seed, Series A opportunities across Health, operating as a Corporate / CVC relevant to Indian founders.
Key signals founders use to decide if this investor is worth a conversation.
Stages and sectors this investor typically backs.
Themes this investor is mapped to across the VC Dekho directory.
Apollo Connect / Apollo Hospitals Ventures focuses on Seed, Series A opportunities across Health, operating as a Corporate / CVC relevant to Indian founders.
1 company mapped to this fund.
Background and context for founders evaluating this investor.
Apollo Connect / Apollo Hospitals Ventures is listed in the VC Dekho investor directory as a Corporate / CVC with activity across Seed, Series A. Its stated sector focus covers Health, which helps founders quickly assess thematic fit before outreach. Cheque sizes vary by opportunity and stage. For Indian founders, the practical use of this profile is stage and sector mapping: if your round and category align, Apollo Connect / Apollo Hospitals Ventures is worth including in a shortlist alongside peer funds with similar mandates. Because public detail can be uneven for smaller firms, family offices, and angel networks, treat cheque and stage fields as directional rather than rigid rules. Founders should validate current thesis, geography preference, and lead vs follow behaviour through recent announcements, warm intros, or a concise first email that references a clear product and traction snapshot. Overall, Apollo Connect / Apollo Hospitals Ventures is best approached with a crisp narrative on why the opportunity fits its stage and sector lens, and what the next milestone funded capital unlocks.
Its stated sector focus covers Health, which helps founders quickly assess thematic fit before outreach.
Apollo Connect / Apollo Hospitals Ventures appears in founder-facing investor maps for Seed, Series A in Health. | Ticket researched: Apollo–IBM healthtech fund planned first cheque ~$5M with follow-on to ~$10M; deal sizes often $5–10M (Entrackr / Unicorn Nest)
Data confidence: Unverified – inferred (template)
Other funds that overlap on stage, sector, or thesis.
Jump into stage, sector, and thesis mapped to this fund.